Treatment patterns and persistence rates with anti‐vascular endothelial growth factor treatment for diabetic macular oedema in the UK: A real‐world study

INTRODUCTION: Anti‐vascular endothelial growth factors (anti‐VEGFs) are considered standard of care therapy for diabetic macular oedema (DME). This study examined treatment patterns and outcomes in patients with DME treated with anti‐VEGF therapy. METHODS: Using anonymized electronic medical record...

Descripción completa

Detalles Bibliográficos
Autores principales: Peto, Tunde, Akerele, Toks, Sagkriotis, Alexandros, Zappacosta, Sofia, Clemens, Andreas, Chakravarthy, Usha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research: Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299692/
https://www.ncbi.nlm.nih.gov/pubmed/34796985
http://dx.doi.org/10.1111/dme.14746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299692/
https://www.ncbi.nlm.nih.gov/pubmed/34796985
http://dx.doi.org/10.1111/dme.14746

Ejemplares similares